3-(Trifluoromethyl)pyrrolidin-3-ol - CAS 196822-27-2
Catalog: |
BB056979 |
Product Name: |
3-(Trifluoromethyl)pyrrolidin-3-ol |
CAS: |
196822-27-2 |
Synonyms: |
3-(trifluoromethyl)pyrrolidin-3-ol |
IUPAC Name: | 3-(trifluoromethyl)pyrrolidin-3-ol |
Description: | 3-(Trifluoromethyl)pyrrolidin-3-ol can be used to prepare TRK kinase inhibitors to treat pain, inflammation, neurodegenerative diseases or cancer of mammals. |
Molecular Weight: | 155.11 |
Molecular Formula: | C5H8NOF3 |
Canonical SMILES: | C1CNCC1(C(F)(F)F)O |
InChI: | InChI=1S/C5H8F3NO/c6-5(7,8)4(10)1-2-9-3-4/h9-10H,1-3H2 |
InChI Key: | PLQLGPQFZLVKTF-UHFFFAOYSA-N |
References: | Qin, Y., et.al. Jiangsu Carephar Pharmaceutical Co., CN111848626 A, (2020). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113429390-A | Quinazoline derivatives and uses thereof | 20200323 |
CN-111662242-A | Heterocyclic IDH mutant inhibitor, preparation method and application thereof | 20190308 |
WO-2019072143-A1 | 4-aminopyridine derivative, pharmaceutical composition thereof, preparation method and application thereof | 20171011 |
US-10662203-B2 | Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection | 20170330 |
US-2018327425-A1 | Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection | 20170330 |
US-2020339603-A1 | Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection | 20170330 |
AU-2017332867-A1 | Indazole compounds for use in tendon and/or ligament injuries | 20160923 |
AU-2017332867-B2 | Indazole compounds for use in tendon and/or ligament injuries | 20160923 |
EP-3515894-A1 | Indazole compounds for use in tendon and/or ligament injuries | 20160923 |
JP-2019529453-A | Indazole compounds for use in tendon and / or ligament injury | 20160923 |
Complexity: | 135 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 155.05579836 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 155.05579836 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 32.3Ų |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS